|
|
|
|
|
|
|
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 1 |
Plenary Lecture ¥° |
ÁÂÀå : ±è¼º¿î |
13:30~14:20 |
A review of current and future treatment strategies of Non-functioning pituitary adenomas |
John Wass,
Oxford University, UK |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 1 |
Plenary Lecture ¥± |
ÁÂÀå : Àӽ±æ |
10:20~11:10 |
Actions of PTH on bone |
H. Kronenberg,
Harvard Univ., USA |
|
|
|
|
|
|
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 1 |
Diabetes & Obesity I - Hepatic insulin resistance |
ÁÂÀå : ÀÌÇü¿ì, Â÷ºÀ¼ö |
10:30~12:00 |
Hepatic insulin resistance vs. Peripheral insulin resistance |
ÃÖö¼ö, °¡ÃµÀÇ´ë |
°£Á¶Á÷°ú ¸»ÃÊ Àν¶¸°°¨¼ö¼º Á¶Á÷ »çÀÌ communication |
ÀÌ´ëÈ£, Á¦ÁÖÀÇ´ë |
Hepatic insulin resistanceÀÇ Ä¡·á |
±èöÈñ, ¼øõÇâÀÇ´ë |
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 1 |
Bone I - Beyond bisphosphonates |
ÁÂÀå : °¹«ÀÏ, Á¤È£¿¬ |
14:20~15:50 |
Denosumab and other developing drugs |
L. Fitzpatrick (GSK, USA) |
Newly developing anabolic agents |
¹é±âÇö, °¡Å縯ÀÇ´ë |
Newly developing (reversible) anti-resorptives |
°íÁ¤¹Î, ¿ï»êÀÇ´ë |
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 3 |
Thyroid I - Graves ophthalmopathy |
ÁÂÀå : ÀÌ»ó¿ , ±Ã¼º¼ö |
16:10~17:40 |
º´ÀÎ ¹× ±âŸ ÃÖ½ÅÁö°ß |
Hiromatsu Yuji,
Kurume Univ., JPN |
½ÇÇèÀû Ä¡·á |
À±Áø¼÷, ¿¬¼¼ÀÇ´ë |
¾È°ú ¼ö¼úÀû Á¢±Ù |
ÃÖÈñ¿µ, ºÎ»êÀÇ´ë |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 2 |
Thyroid II - Thyroid cancer |
ÁÂÀå : Á¶º¸¿¬, ¼Û¿µ±â |
08:30~10:00 |
Epigenetic dysregulation in thyroid cancer |
Tetsuo Kondo, Yamanashi Univ., JPN |
(18)F-FDG Uptake and Biological Markers in Thyroid Cancer |
±èÀÎÁÖ, ºÎ»êÀÇ´ë |
°©»ó¼± ¾Ï¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¾ÏÀüÀÌ ¿¬±¸ ¸ðµ¨ ±¸Ãà |
±èÅ¿ë, ¿ï»êÀÇ´ë |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 3 |
Bone II - Anabolic signals: Parathyroids and IGFs |
ÁÂÀå : ½ÅÂù¼ö, ÃÖÁ¦¿ë |
08:30~10:00 |
Role of Ephrins in the regulation of bone formation |
S. Mohan ,
Loma Linda Univ., USA |
PTH and SOST |
ÀÌÀ¯¹Ì, ¿¬¼¼ÀÇ´ë |
Hypoparathyroidism and GCMB |
À̽ÃÈÆ, °¡ÃµÀÇ´ë |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 2 |
Diabetes & Obesity II - Stem cell therapy in diabetic vascular complications |
ÁÂÀå : À̸í½Ä, À±°ÇÈ£ |
11:10~12:40 |
Mesenchymal stem cell therapy for lower extremity ischemia |
±èº´¼ö, ¼¿ï°ø´ë |
Ç÷°ü³»ÇÇ Àü±¸¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á |
±Ç»ó¸ð, CHAÀÇ°úÇдëÇб³ |
Stem cell therapy in ischemic cardiovascular disease |
ÀÓµµ¼±, °í·ÁÀÇ´ë |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 3 |
Vascular biology |
ÁÂÀå : ±èÀÎÁÖ, À¯¼øÁý |
11:10~12:40 |
Intravenous Endothelial-like Cells Differentiated from Mesenchymal Stem Cells Accelerate Reendothelialization in Balloon-injured Rat |
Ȳ±âö, ¿¬¼¼ÀÇ´ë |
Homing and differentiation of endothelial progenitor cell |
±Ç¿µ±Ù, ¿¬¼¼´ë |
Establishment of endothelial stem cells from embryonic stem cells |
°í±Ô¿µ, KAIST |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 2 |
Vascular imaging - Imaging of atherosclerosis |
ÁÂÀå : ±èµÎ¸¸, ÀÌÀºÁ÷ |
15:50~17:20 |
MRI imaging of atherosclerosis |
Çã¿ë¹Î, SIRIC |
Peptide Probe-Based Targeted Imaging of Atherosclerosis |
À̺´Çå, °æºÏÀÇ´ë |
CT imaging of atherosclerosis |
ÃÖº´¿í, ¿¬¼¼ÀÇ´ë |
11¿ù 20ÀÏ(Åä) - °ÀÇ½Ç 3 |
Aging and endocrine change |
ÁÂÀå : ¿ìÁ¤ÅÃ, °í°æ¼ö |
15:50~17:20 |
Aging, sarcopenia and diabetes |
¹Ú¼®¿ø, CHAÀÇ°úÇдëÇб³ |
Aging and osteoporosis |
¿À±â¿ø, ¼º±Õ°üÀÇ´ë |
Aging and changes in somatotropic axis |
±èµ¿¼±, ÇѾçÀÇ´ë |
|
|
|
|
|
|
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö I - ÁÁÀº¿¬±¸¸¦ À§ÇÑ ÀÇ·áÀ±¸®¿Í ¿¬±¸»ç¾÷ÀÇ ÀÌÇØ |
ÁÂÀå: À¯ÇüÁØ, ¹Úż± |
08:40~10:10 |
»ç¶÷À» ´ë»óÀ¸·Î ÇÏ´Â ¿¬±¸À±¸® |
±è¿ÁÁÖ, ¼¿ïÀÇ´ë ÀÇ»çÇб³½Ç |
¿¬±¸ÀÚÀÇ ±Û¾²±â À±¸® |
ÀÌÀÎÀç, ¼¿ï±³´ë |
³»ºÐºñ ¿¬±¸ÀÚ¸¦ À§ÇÑ ±¹Ã¥¿¬±¸ºñ ¼Ò°³ (¿¬±¸ºñ Á¾·ù¿Í °èȹ¼ ÀÛ¼º) |
ÀÌÀαÔ, °æºÏÀÇ´ë |
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö ¥± - ³»ºÐºñ Á¾¾çÀÇ Áø´Ü ¹× »õ·Î¿î Ä¡·áÁ¦ |
ÁÂÀå: ±èµ¿¼±, ¹ÚµµÁØ |
10:30~12:00 |
The Efficacy and safety of Pasireotide in Acromegaly and Cushing¡¯s syndrome |
±è¹Î¼±, ¿ï»êÀÇ´ë |
Medical treatment of pancreatic neuroendocrine tumor |
ÀåÈï¹®, ¿ï»êÀÇ´ë |
Novel B-raf kinase inhibitor °³¹ß |
½Éź¸, KIST |
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö¥² - Drug discovery and development in endocrinology and metabolism |
ÁÂÀå: ¹Ú°æ¼ö, ¼Û¹ÎÈ£ |
14:20~15:50 |
´ç´¢º´ Ä¡·áÁ¦ÀÇ ÃÖ±Ù °³¹ßµ¿Çâ |
õÇý°æ,
°¡ÃµÀÇ´ë ¾à¸®Çб³½Ç |
Drug discovery in metabolic syndrome: focus on adipokines |
Gary Sweeny,
Institut Pasteur Korea |
°æ±¸¿ë Ç÷´ç°ÇÏÁ¦ Á¦¹Ì±Û¸³Æ¾ÀÇ ¿¬±¸°³¹ß »ç·Ê |
ÀÓÇöÁÖ, LG»ý¸í°úÇÐ |
11¿ù 19ÀÏ(±Ý) - °ÀÇ½Ç 2 |
Çп¬»ê ½ÉÆ÷Áö¾ö¥³ - U-healthcare in Endocrinology |
ÁÂÀå: ÀåÇÐö, ·ùÁØ¿À |
16:10~17:40 |
»óÈ£ ¿¬µ¿Àû À¯ÇコÄɾ ÀÌ¿ëÇÑ ´ç´¢º´ °ü¸® ¹× ½º¸¶Æ®ÄÉ¾î »ç¾÷ |
¹ÚÁß¿, ¿ï»êÀÇ´ë |
Application of ubiquitous healthcare service using new medical information system in elderly diabetic patients |
ÀÓ¼ö, ¼¿ïÀÇ´ë |
À¯Çコ ¼ºñ½º ÇöȲ ¹× À̽´ |
¾È½ÃÈÆ, ºñÆ®ÄÄÇ»ÅÍ |
Biosensors for U-Healthcare |
Á¤ºÀÇö, KRIBB |
|
|
|
|
|